Home Cart Sign in  
Chemical Structure| 1252679-52-9 Chemical Structure| 1252679-52-9

Structure of ITX5061
CAS No.: 1252679-52-9

Chemical Structure| 1252679-52-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ITX5061 is a type II inhibitor of p38 MAPK and also an antagonist of scavenger receptor B1 (SR-B1).

Synonyms: ITX5061

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ITX5061

CAS No. :1252679-52-9
Formula : C30H38ClN3O7S
M.W : 620.16
SMILES Code : O=C(NC1=CC(C(C)(C)C)=CC(NS(=O)(C)=O)=C1OC)C(C2=C3C=CC=CC3=C(OCCN4CCOCC4)C=C2)=O.[H]Cl
Synonyms :
ITX5061
MDL No. :MFCD30532738

Safety of ITX5061

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of ITX5061

MAPK
TLR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01165359 Hepatitis C Phase 1 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS Birmingham, Alabama, United States, 35294-2050 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 Ucsd, Avrc Crs San Diego, California, United States, 92103 Ucsf Aids Crs San Francisco, California, United States, 94110 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, New York Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Duke Univ. Med. Ctr. Adult CRS Durham, North Carolina, United States, 27710 United States, Ohio Univ. of Cincinnati CRS Cincinnati, Ohio, United States, 45267-0405 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Puerto Rico Puerto Rico-AIDS CRS San Juan, Puerto Rico, 00935 Less <<
NCT01560468 Hepatitis C Infection Phase 1 Terminated(Financial Reasons) - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT01292824 Hepatitis C E... More >>vidence of Liver Transplantation Less << Phase 1 Completed - United Kingdom ... More >> University Hospital Birmingham Birmingham, West Midlands, United Kingdom, B15 2TH Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.61mL

0.32mL

0.16mL

8.06mL

1.61mL

0.81mL

16.12mL

3.22mL

1.61mL

References

 

Historical Records

Categories